ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 173 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $326,000 | -12.4% | 26,210 | -3.6% | 0.00% | 0.0% |
| Q3 2016 | $372,000 | +73.8% | 27,200 | -6.2% | 0.00% | 0.0% |
| Q2 2016 | $214,000 | +36.3% | 29,000 | +18.4% | 0.00% | +100.0% |
| Q1 2016 | $157,000 | -23.4% | 24,500 | -25.3% | 0.00% | -50.0% |
| Q4 2015 | $205,000 | +81.4% | 32,800 | +69.9% | 0.00% | +100.0% |
| Q3 2015 | $113,000 | -28.0% | 19,300 | +1.6% | 0.00% | 0.0% |
| Q2 2015 | $157,000 | +149.2% | 19,005 | +149.6% | 0.00% | 0.0% |
| Q1 2015 | $63,000 | -3.1% | 7,615 | -21.3% | 0.00% | 0.0% |
| Q4 2014 | $65,000 | -31.6% | 9,675 | -45.4% | 0.00% | 0.0% |
| Q3 2014 | $95,000 | +28.4% | 17,725 | +50.0% | 0.00% | 0.0% |
| Q2 2014 | $74,000 | -3.9% | 11,815 | +20.4% | 0.00% | 0.0% |
| Q1 2014 | $77,000 | +92.5% | 9,815 | +68.8% | 0.00% | 0.0% |
| Q4 2013 | $40,000 | -82.9% | 5,815 | -54.3% | 0.00% | -80.0% |
| Q3 2013 | $234,000 | +169.0% | 12,715 | +154.5% | 0.01% | +150.0% |
| Q2 2013 | $87,000 | – | 4,996 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $80,313,000 | 15.61% |
| Opaleye Management Inc. | 1,310,000 | $8,188,000 | 3.42% |
| Camber Capital Management LP | 5,405,235 | $33,783,000 | 2.18% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 471,516 | $2,947,000 | 1.22% |
| HighVista Strategies LLC | 807,100 | $5,044,000 | 0.94% |
| JS Capital Management LLC | 630,000 | $3,938,000 | 0.94% |
| 1492 Capital Management LLC | 202,500 | $1,266,000 | 0.92% |
| Palo Alto Investors LP | 2,257,217 | $14,108,000 | 0.78% |
| Geduld E E | 185,100 | $1,157,000 | 0.72% |
| Elk Creek Partners, LLC | 1,592,527 | $9,953,000 | 0.71% |